UNCY
NASDAQ · Biotechnology
Unicycive Therapeutics Inc
$4.69
-3.01 (-39.09%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+33.7% upside
Low Target
$3.63
Average Target
$6.27
High Target
$7.20
Current Price
$4.69
Current
$4.69
$4.69
Target
$6.27
$6.27
$3.63
$6.27 avg
$7.20
Scenario Analysis
Bear Case
$3.63
-22.6%
Low target
Base Case
$6.27
+33.7%
Avg target
Bull Case
$7.20
+53.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$8.74
-46.3% from high
52-Week Low
$3.71
+26.4% from low
Target vs 52W High
$6.27
-28.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +2.4% |
| AMGN | Hold | 44 | 50% | $190.87 | -47.3% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +187.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.8% |
| REGN | Buy | 38 | 71% | $76.80 | -87.7% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -66.0% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -39.1% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -47.4% |